July 19, 2023 02:57 PM EDTUpdated July 20, 07:04 AM
Pharma
Law

SEC fines for­mer Mer­ck ex­ec over in­sid­er trad­ing al­le­ga­tions

Paul Schloesser

Associate Editor

The Se­cu­ri­ties and Ex­change Com­mis­sion said a for­mer Mer­ck ex­ec­u­tive agreed to pay $82,000 af­ter al­leg­ing he pur­chased shares of a com­pa­ny right be­fore it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times